Roberto G. S. Berlinck
University of British Columbia
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Roberto G. S. Berlinck.
Nature | 2014
Eduardo V. Mercado-Marin; Pablo García-Reynaga; Stelamar Romminger; Eli F. Pimenta; David K. Romney; Michael W. Lodewyk; David E. Williams; Raymond J. Andersen; Scott J. Miller; Dean J. Tantillo; Roberto G. S. Berlinck; Richmond Sarpong
Many natural products that contain basic nitrogen atoms—for example alkaloids like morphine and quinine—have the potential to treat a broad range of human diseases. However, the presence of a nitrogen atom in a target molecule can complicate its chemical synthesis because of the basicity of nitrogen atoms and their susceptibility to oxidation. Obtaining such compounds by chemical synthesis can be further complicated by the presence of multiple nitrogen atoms, but it can be done by the selective introduction and removal of functional groups that mitigate basicity. Here we use such a strategy to complete the chemical syntheses of citrinalin B and cyclopiamine B. The chemical connections that have been realized as a result of these syntheses, in addition to the isolation of both 17-hydroxycitrinalin B and citrinalin C (which contains a bicyclo[2.2.2]diazaoctane structural unit) through carbon-13 feeding studies, support the existence of a common bicyclo[2.2.2]diazaoctane-containing biogenetic precursor to these compounds, as has been proposed previously.
Planta Medica | 2011
Andre G. Tempone; Camila Martins de Oliveira; Roberto G. S. Berlinck
Leishmaniasis is a neglected infectious disease caused by kinetoplastid protozoans. An urgent need for novel chemotherapeutics exists. The current approaches to discover new antileishmanial compounds present many drawbacks, including high-cost and time-consuming bioassays. Thus, advances in leishmaniasis treatment are limited, and the development of screening assays is hindered. The combination of multidisciplinary approaches using standardised methods and synchronous projects could be an alternative to develop novel drugs for leishmaniasis treatment. In this review, we discuss the current status of leishmaniasis occurrence and treatment. In addition, we address the advantages and limitations of in vitro leishmaniasis bioassays and discuss the findings of drug discovery research using natural products. Finally, we comprehensively review the marine natural products that are active against Leishmania spp., including their natural sources and bioactivity profile.
Journal of Natural Products | 2008
Miriam H. Kossuga; Andréa Mendes do Nascimento; Juliana Q. Reimão; Andre G. Tempone; Noemi Nosomi Taniwaki; Katyuscya Veloso; Antonio G. Ferreira; Bruno C. Cavalcanti; Cláudia Pessoa; Manoel Odorico de Moraes; Alejandro M. S. Mayer; Eduardo Hajdu; Roberto G. S. Berlinck
Investigation of the bioactive crude extract from the sponge Plakortis angulospiculatus from Brazil led to the isolation of plakortenone ( 1) as a new polyketide, along with five known polyketides ( 2- 6) previously isolated from other Plakortis sponges. The known polyketides were tested in antileishmanial, antitrypanosomal, antineuroinflammatory, and cytotoxicity assays. The results show that plakortide P ( 3) is a potent antiparasitic compound, against both Leishmania chagasi and Trypanosona cruzi, and exhibited antineuroinflammatory activity. The known polyketides 2- 6 were tested for cytotoxicity against four human cancer cell lines, but displayed only moderate cytotoxic activity.
The Journal of Antibiotics | 2006
Simone P. Lira; Aline M. Vita-Marques; Mirna H. R. Seleghim; Tim S. Bugni; Daniel V. LaBarbera; Lara Durães Sette; Sandra Regina Pombeiro Sponchiado; Chris M. Ireland; Roberto G. S. Berlinck
Chemical investigation of the cytotoxic and anti-tuberculosis active butanone extract obtained from the growth media of the marine-derived fungus Beauveria felina led to the isolation of two new destruxins, [β-Me-Pro] destruxin E chlorohydrin (1) and pseudodestruxin C (3), along with five known cyclic depsipeptides. The structures of the new destruxin derivatives were established by analysis of spectroscopic data, while the absolute configuration of the common amino acid residues was established by Marfeys analysis. The absolute configuration of the 2(R),4(S)-5-chloro-2,4-dihydroxypentanoic acid residue in 1 could be established by application of a J-based configuration method followed by derivatization with R-MPA-Cl and NMR analysis.
Journal of Natural Products | 2010
Eli F. Pimenta; Aline M. Vita-Marques; Aristeu Tininis; Mirna H. R. Seleghim; Lara Durães Sette; Katyuscya Veloso; Antonio G. Ferreira; David E. Williams; Brian O. Patrick; Doralyn S. Dalisay; Raymond J. Andersen; Roberto G. S. Berlinck
A fractional factorial design approach has been used to enhance secondary metabolite production by two Penicillium strains. The method was initially used to improve the production of bioactive extracts as a whole and subsequently to optimize the production of particular bioactive metabolites. Enhancements of over 500% in secondary metabolite production were observed for both P. oxalicum and P. citrinum. Two new alkaloids, citrinalins A (5) and B (6), were isolated and identified from P. citrinum cultures optimized for production of minor metabolites.
Journal of Natural Products | 2015
Mario F. C. Santos; Philip M. Harper; David E. Williams; Juliana T. Mesquita; Erika G. Pinto; Thais A. Costa-Silva; Eduardo Hajdu; Antonio G. Ferreira; Raquel Alves dos Santos; Patrick J. Murphy; Raymond J. Andersen; Andre G. Tempone; Roberto G. S. Berlinck
HPLC-UV-ELSD-MS-guided fractionation of the anti-parasitic extract obtained from the marine sponge Monanchora arbuscula, collected off the southeastern coast of Brazil, led to the isolation of a series of guanidine and pyrimidine alkaloids. The pyrimidines monalidine A (1) and arbusculidine A (7), as well as the guanidine alkaloids batzellamide A (8) and hemibatzelladines 9-11, represent new minor constituents that were identified by analysis of spectroscopic data. The total synthesis of monalidine A confirmed its structure. Arbusculidine A (7), related to the ptilocaulin/mirabilin/netamine family of tricyclic guanidine alkaloids, is the first in this family to possess a benzene ring. Batzellamide A (8) and hemibatzelladines 9-11 represent new carbon skeletons that are related to the batzelladines. Evaluation of the anti-parasitic activity of the major known metabolites, batzelladines D (12), F (13), L (14), and nor-L (15), as well as of synthetic monalidine A (1), against Trypanosoma cruzi and Leishmania infantum is also reported, along with a detailed investigation of parasite cell-death pathways promoted by batzelladine L (14) and norbatzelladine L (15).
Journal of Natural Products | 2002
Beatriz M. Saeki; Ana Claudia Granato; Roberto G. S. Berlinck; Alviclér Magalhães; Alexandre B. Schefer; Antonio G. Ferreira; Ulisses Pinheiro; Eduardo Hajdu
Two new bromotyrosine-derived alkaloids, caissarine A (1) and caissarine B (2), along with three known biogenetically related alkaloids, aeroplysinin-1, fistularin-3, and the artifact of isolation 2-(3,5-dibromo-4-dimethoxy-1-hydroxy-2,5-cyclohexadien-1-yl)ethanamide, have been isolated from Aplysina caissara, an endemic species of marine sponge from the Southeastern Brazilian coast. The alkaloids have been identified by analysis of spectroscopic data. While caissarine A has a 2-hydroxyagmatine moiety in its structure, caissarin B is the first naturally occurring compound encompassing the unprecedented 1,7-diamino-3-hydroxyheptane moiety.
Journal of Natural Products | 2011
Fernanda R. da Silva; Ana Claudia Tessis; Patricia F. Ferreira; Luciana P. Rangel; Aline S. Garcia-Gomes; Fabio R. Pereira; Roberto G. S. Berlinck; Guilherme Muricy; Antonio Ferreira-Pereira
Oroidin was isolated from the marine sponge Agelassventres and inhibited the activity and function of Pdr5p, an enzyme responsible for the multidrug resistance phenotype in Saccharomyces cerevisiae. This compound may help in the development of new drugs that reverse this dangerous phenotype of pathogenic yeast and fungi.
Journal of Natural Products | 2016
Ligia F. Martins; Juliana T. Mesquita; Erika G. Pinto; Thais A. Costa-Silva; Samanta Etel Treiger Borborema; Andres J. Galisteo Junior; Bruno J. Neves; Carolina H. Andrade; Zainab Al Shuhaib; Elliot L. Bennett; Gregory P. Black; Philip M. Harper; Daniel M. Evans; Hisham S. Fituri; John P. Leyland; Claire Martin; Terence D. Roberts; Andrew J. Thornhill; Stephen A. Vale; Andrew Howard-Jones; Dafydd A. Thomas; Harri Lloyd Williams; Larry E. Overman; Roberto G. S. Berlinck; Patrick J. Murphy; Andre G. Tempone
Synthetic analogues of marine sponge guanidine alkaloids showed in vitro antiparasitic activity against Leishmania (L.) infantum and Trypanosoma cruzi. Guanidines 10 and 11 presented the highest selectivity index when tested against Leishmania. The antiparasitic activity of 10 and 11 was investigated in host cells and in parasites. Both compounds induced depolarization of mitochondrial membrane potential, upregulation of reactive oxygen species levels, and increased plasma membrane permeability in Leishmania parasites. Immunomodulatory assays suggested an NO-independent effect of guanidines 10 and 11 on macrophages. The same compounds also promoted anti-inflammatory activity in L. (L.) infantum-infected macrophages cocultived with splenocytes, reducing the production of cytokines MCP-1 and IFN-γ. Guanidines 10 and 11 affect the bioenergetic metabolism of Leishmania, with selective elimination of parasites via a host-independent mechanism.
Organic Letters | 2015
Everton L. F. Ferreira; David E. Williams; Laura P. Ióca; Raquel P. Morais-Urano; Mario F. C. Santos; Brian O. Patrick; Luciana M. Elias; Simone P. Lira; Antonio G. Ferreira; Michel R. Z. Passarini; Lara Durães Sette; Raymond J. Andersen; Roberto G. S. Berlinck
The structure of the fungal metabolite roussoellatide (1) has been established by spectroscopic and X-ray diffraction analyses. Results from feeding experiments with [1-(13)C]acetate, [2-(13)C]acetate, and [1,2-(13)C]acetate were consistent with a biosynthetic pathway to the unprecedented skeleton of 1 involving Favorskii rearrangements in separate pentaketides, subsequently joined via an intermolecular Diels-Alder reaction.